Diligence memo · auto-generated · as of July 2, 2026
Immunocept Medical Products, LLC
Immunocept Medical Products, LLC looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Immunocept Medical Products, LLC operates in Manufacturing, based in DENVER.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Immunocept Medical Products, LLC has raised $530K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $530K on 2017-04-24.
Most recent recorded round closed around 2017-04-24.
Valuation (modeled)modeled
Provath models Immunocept Medical Products, LLC at approximately $8.1M (range $360K–$92M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.51× the median modeled value of Pre-Seed Manufacturing companies in 2016–2018 (231 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 9.2 yr ago; this sector typically re-raises about every 12 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 24% of Manufacturing peers (3257 compared).
Modeled value ranks above 42% of those peers.
Closest niche peers: Thorp Lane, Inc., NANOPHASE TECHNOLOGIES Corp, WholeMe, LLC, Shock Mitigation Technologies, Inc, Southwood Holding Company, Inc..
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.